English
Select your language
Official EU languages:
Access to European Union law
EUR-Lex
Access to European Union law
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
Document 62013CN0210
Case C-210/13
Court of Justice
Status: Closed
Court of Justice
Status: Closed
/
DECISION
- Title
- Euroopa Kohtu määrus (kaheksas koda), 14.11.2013. Glaxosmithkline Biologicals SA ja Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG versus Comptroller General of Patents, Designs and Trade Marks. Eelotsusetaotlus, mille on esitanud High Court of Justice (England & Wales), Chancery Division. Inimtervishoius kasutatavad ravimid – Täiendava kaitse tunnistus – Määrus (EÜ) nr 469/2009 – Mõisted „toimeaine” ja „toimeainete kombinatsioon” – Vaktsiiniabiaine. Kohtuasi C‑210/13.
- ECLI identifier
- ECLI:EU:C:2013:762
- Judge-Rapporteur
- Toader
- Type of procedure
- Eelotsusetaotlus
- Complementary documents:
07/04/2014
- Title
- Euroopa Kohtu määrus (kaheksas koda), 14.11.2013. Glaxosmithkline Biologicals SA ja Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG versus Comptroller General of Patents, Designs and Trade Marks. Eelotsusetaotlus, mille on esitanud High Court of Justice (England & Wales), Chancery Division. Inimtervishoius kasutatavad ravimid – Täiendava kaitse tunnistus – Määrus (EÜ) nr 469/2009 – Mõisted „toimeaine” ja „toimeainete kombinatsioon” – Vaktsiiniabiaine. Kohtuasi C‑210/13.
- ECLI identifier
- ECLI:EU:C:2013:762
- Judge-Rapporteur
- Toader
- Type of procedure
- Eelotsusetaotlus
14/11/2013
CASE BROUGHT
- Title
- Kohtuasi C-210/13: Eelotsusetaotlus, mille on esitanud High Court of Justice (Chancery Division) (Ühendkuningriik) 18. aprillil 2013 — Glaxosmithline Biologicals SA ja Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG versus Comptroller-General of Patents, Designs and Trade Marks
29/06/2013